Monday, June 16, 2025

Latest

PharmaDrug: A Path To Safe Supply

FULL DISCLOSURE: This content is sponsored by PharmaDrug Inc.

In this interview, David Kideckel, CEO of PharmaDrug (CSE: PHRX), discusses the company’s groundbreaking biosynthetic manufacturing method for pharmaceutical-grade cocaine. The focus is on addressing the fentanyl crisis and providing safe supply programs for overcoming illicit drug addiction. PharmaDrug aims to combat substance abuse through biosynthesis, ensuring consistent, pure, and cost-effective production of cocaine.

READ: Biosynthetic Cocaine? PharmaDrug Files Patent For Novel Manufacturing Method

David highlights the company’s history, his background, and potential markets, emphasizing harm reduction. The interview explores revenue opportunities, scalability, and ongoing regulatory efforts.


FULL DISCLOSURE: PharmaDrug is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of PharmaDrug. The author has been compensated to cover PharmaDrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

First Majestic Silver: The Santa Elena Mine

Equinox Gold: Guidance Cut After Issues At Greenstone

Simply Solventless Q4 Earnings: So Much For Guidance

Recommended

Power Metallic Secures Jabal Baudan Project In Saudi Arabia

NexGen Energy Receives Approval For Site Expansion At Rook I Project

Related News

Pharmadrug Signs Five Year Supply Agreement With Canada House Wellness

Canada House Wellness (CSE: CHV) and Pharmadrug (CSE: BUZZ) jointly announced today a five year...

Thursday, October 31, 2019, 12:20:18 PM

PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening

PharmaDrug (CSE: PHRX) is reporting this morning that cepharanthine, of which their subsidiary has developed...
Wednesday, August 21, 2024, 10:26:03 AM

PharmaDrug Names Dr David Kideckel As Chairman, While SecureDose Finalizes Formulation

PharmaDrug (CSE: PHRX) this morning released a series of updates, headlined by the appointment of...
Tuesday, February 27, 2024, 09:44:15 AM

PharmaDrug JV Submits Application For Phase 1 Clinical Trials In Australia

PharmaDrug Inc (CSE: DRUG) has seen one of its joint ventures advance to the clinical...
Wednesday, May 15, 2024, 09:17:48 AM

Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a...

Tuesday, May 31, 2022, 10:34:00 AM